ArticleFrontiers in immunology2025

Dual BLyS/APRIL targeted therapy with telitacicept in rituximab-refractory SLE-associated neuromyelitis optica spectrum disorder: a case report.

Mingfen Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.